Kirstin Liechty

Kirstin Liechty has a diverse work experience in the field of clinical operations and research. Kirstin is currently working at A2 Biotherapeutics, Inc. as the Sr. Director of Clinical Operations, a role they have held since June 2023. Prior to this, they were the Director of Clinical Operations at the same company from January 2021 to June 2023.

Before joining A2 Biotherapeutics, Inc., Kirstin served as the President of K2 Consulting Incorporated from January 2020 to January 2021. Kirstin also worked at Novella Clinical as a Senior Clinical Project Manager from September 2018 to December 2019.

Kirstin has held various roles in the clinical project management field. Kirstin worked at Celyad as a Clinical Project Manager from January 2018 to September 2018, and at IQVIA as a Clinical Project Manager from October 2016 to December 2017.

Kirstin'searlier experience includes working at Chiltern as a Clinical Trial Manager from December 2010 to October 2016. In this role, they managed global phase I-IV studies in multiple countries, led project CRA teams, and handled time, finance, and risk management. Kirstin also worked at Covance as a Senior Clinical Research Associate from December 2008 to December 2010, and at UBC - An Express Scripts Company as a Clinical Research Associate from November 2006 to December 2008.

Kirstin'scareer began at Centocor, where they served as a Clinical Trial Associate from November 2004 to November 2006. Kirstin gained expertise in oncology therapies and conducted various study-related activities. Prior to that, Kirstin worked as a Senior Research Technician at The Children's Hospital of Philadelphia from October 2002 to November 2004.

Kirstin Liechty attended the University of Arizona from 1996 to 2000, where they obtained a Bachelor of Science (BS) degree in Microbiology and Immunology.